Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Dividend investing for retirement -- Ignore unavailable to you. Want to Upgrade?

To: Triffin who wrote (8813)	4/29/2011 3:51:14 PM
From: Bocor	Read Replies (1) \| Respond to of 34328

Abbott Receives U.S. FDA Approval for AndroGel® 1.62% to Treat Men with Low TestosteroneNew, Low-Volume Formulation to Help Restore Low Testosterone Levels in Men.

To: Triffin who wrote (8813)	4/29/2011 4:03:50 PM
From: Steve Felix	Respond to of 34328

You got that right! People give me a laugh though. My youngest had 11.5k in Vanguard Prime Money Market Fund. Made less than $10 last year. She used 5k to fund her Roth this year, and we converted her to a brokerage account. I bought her 300 NQP and 50 MHR_pd. Her income will be $39.30 a month compared to her best month at $1.40 last year. Partly tax free income. She says "ya know Vanguard is going to charge me a $20 annual fee for not having at least $3,000 in my money market account." I just slapped my forehead and laughed.